Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the appointments of Andre Hoekema as chairman of the board and Cora Griffin as head of business development. 2 October 2024
NK:IO, a London startup developing a cell therapy for treating solid tumors, has announced the appointment of a permant chief executive and the finalization of a seed funding round. 2 October 2024
Halda Therapeutics, a US biotech company advancing cancer treatments, announced the appointment of Christian Schade as president and chief executive. 1 October 2024
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has announced the appointment of Jane Rhodes as chief executive officer. 1 October 2024
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
USA-based engineered regulatory T cells (Tregs) company GentiBio today announced the appointment of Dr Mark Bach as chief medical officer. 30 September 2024
Acadia Pharmaceuticals has appointed Catherine Owen Adams to succeed Steve Davis as chief executive (CEO) and a member of its board of directors. 28 September 2024
Recently-created by US biotech incubator Flagship Pioneering, Abiologics has announced the appointment of Maria-Chiara Magnone as its chief scientific officer. 26 September 2024
German privately-held biotech ARTCLINE Bio-Therapies today announced the appointment of Dirk Hessel as additional managing director of the company. 23 September 2024
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
US clinical-stage biotech firm Pfenex today announced the appointment of Evert (Eef) Schimmelpennink as chief executive, president, and secretary effective August 3, 2017. 3 August 2017
Trying to control investor and media relations for Anglo-Swedish pharma major AstraZeneca remains an unenviable task, with leaks now appearing to suggest that chief executive Pascal Soriot is staying. 24 July 2017
The share price of Canada-based Aeterna Zentaris’ had shot up by nearly 200% to $3.01 by Friday lunchtime compared to Tuesday’s close, with the company considering what to do with new-found success. 21 July 2017
AstraZeneca’s chief executive Pascal Soriot is the leading candidate to be the CEO of Israel’s generics giant Teva Pharmaceutical Industries, according to Israeli newspapers Haaretz and Calcalist. 13 July 2017
US biotech major Biogen has brought in a woman with a background in both biopharma and the public sector as its new vice president of governmental affairs. 11 July 2017
Ferring Pharmaceuticals says that Lars Peter Brunse has been appointed executive vice president and chief production officer, and made a member of the Ferring executive board, effective immediately. 5 July 2017
Following swiftly on last week’s shareholders rejected takeover bid for Stada Arzneimittel (SAZ: Xetra) by private equity firms Bain Capital and Cinven, two of the companies top executives have proffered their resignations. 4 July 2017
As talks begin in earnest on the UK’s departure from the European Union, the trade group European Federation of Pharmaceutical Industries and Associations (EFPIA) expresses its concern that the Heads of State on Thursday decided to postpone a resolution on the relocation of the European Medicines Agency until November this year. 26 June 2017
Danish drugmaker LEO Pharma today announced that it appointed Chris Posner as executive vice president Region US and president and chief executive LEO Pharma Inc. 23 June 2017
US fertility treatment specialist OvaScience will cut its workforce and appoint a new chief executive, Christopher Kroeger, in a bid to slow the company’s cash burn rate and focus on key clinical development goals. 22 June 2017
UK clinical-stage biopharma firm Verona Pharma today announced the appointment of Desiree Luthman to the company’s executive team as vice president, regulatory affairs. 22 June 2017
US biotech major Biogen has appointed Jean-Paul Kress as executive vice president and president, International, and head of global therapeutic operations, effective June 19. 15 June 2017